De novo STXBP1 mutations in mental retardation and nonsyndromic epilepsy
- PMID: 19557857
- DOI: 10.1002/ana.21625
De novo STXBP1 mutations in mental retardation and nonsyndromic epilepsy
Abstract
We sequenced genes coding for components of the SNARE complex (STX1A, VAMP2, SNAP25) and their regulatory proteins (STXBP1/Munc18-1, SYT1), which are essential for neurotransmission, in 95 patients with idiopathic mental retardation. We identified de novo mutations in STXBP1 (nonsense, p.R388X; splicing, c.169+1G>A) in two patients with severe mental retardation and nonsyndromic epilepsy. Reverse transcriptase polymerase chain reaction and sequencing showed that the splicing mutation creates a stop codon downstream of exon-3. No de novo or deleterious mutations in STXBP1 were found in 190 control subjects, or in 142 autistic patients. These results suggest that STXBP1 disruption is associated with autosomal dominant mental retardation and nonsyndromic epilepsy.
Similar articles
-
Therapeutic benefits of ACTH and levetiracetam in STXBP1 encephalopathy with a de novo mutation: A case report and literature review.Medicine (Baltimore). 2018 May;97(18):e0663. doi: 10.1097/MD.0000000000010663. Medicine (Baltimore). 2018. PMID: 29718889 Free PMC article. Review.
-
Clinical spectrum of early-onset epileptic encephalopathies associated with STXBP1 mutations.Neurology. 2010 Sep 28;75(13):1159-65. doi: 10.1212/WNL.0b013e3181f4d7bf. Neurology. 2010. PMID: 20876469
-
Paternal mosaicism of an STXBP1 mutation in OS.Clin Genet. 2011 Nov;80(5):484-8. doi: 10.1111/j.1399-0004.2010.01575.x. Epub 2010 Nov 10. Clin Genet. 2011. PMID: 21062273
-
De novo SYNGAP1 mutations in nonsyndromic intellectual disability and autism.Biol Psychiatry. 2011 May 1;69(9):898-901. doi: 10.1016/j.biopsych.2010.11.015. Epub 2011 Jan 15. Biol Psychiatry. 2011. PMID: 21237447
-
STXBP1 encephalopathy: A neurodevelopmental disorder including epilepsy.Neurology. 2016 Mar 8;86(10):954-62. doi: 10.1212/WNL.0000000000002457. Epub 2016 Feb 10. Neurology. 2016. PMID: 26865513 Review.
Cited by
-
SPTAN1 encephalopathy: distinct phenotypes and genotypes.J Hum Genet. 2015 Apr;60(4):167-73. doi: 10.1038/jhg.2015.5. Epub 2015 Jan 29. J Hum Genet. 2015. PMID: 25631096 Review.
-
Analysis of trio test in neurodevelopmental disorders.Front Pediatr. 2022 Dec 23;10:1073083. doi: 10.3389/fped.2022.1073083. eCollection 2022. Front Pediatr. 2022. PMID: 36619507 Free PMC article.
-
Clinical whole exome sequencing revealed de novo heterozygous stop-gain and missense variants in the STXBP1 gene associated with epilepsy in Saudi families.Saudi J Biol Sci. 2022 Jul;29(7):103309. doi: 10.1016/j.sjbs.2022.103309. Epub 2022 May 20. Saudi J Biol Sci. 2022. PMID: 35663845 Free PMC article.
-
Therapeutic benefits of ACTH and levetiracetam in STXBP1 encephalopathy with a de novo mutation: A case report and literature review.Medicine (Baltimore). 2018 May;97(18):e0663. doi: 10.1097/MD.0000000000010663. Medicine (Baltimore). 2018. PMID: 29718889 Free PMC article. Review.
-
Protein instability, haploinsufficiency, and cortical hyper-excitability underlie STXBP1 encephalopathy.Brain. 2018 May 1;141(5):1350-1374. doi: 10.1093/brain/awy046. Brain. 2018. PMID: 29538625 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical